Cyclic AMP-mobilizing agents and glucocorticoids modulate human smooth muscle cell migration

Area of Science:

• Pulmonary Medicine
• Cell Biology
• Pharmacology

Background:

• Smooth muscle cell hyperplasia and migration are key in airway and pulmonary vascular diseases.
• The regulatory mechanisms of lung smooth muscle cell migration are not fully understood.

Purpose of the Study:

• To investigate the effects of cAMP-mobilizing agents and steroids on smooth muscle cell migration in the lungs.
• To elucidate the cellular and molecular mechanisms governing smooth muscle cell migration.

Main Methods:

• Assessed the impact of various growth factors (PDGF, TGF-α, VEGF, bFGF) on pulmonary vascular smooth muscle (PVSM) and airway smooth muscle (ASM) cell migration.
• Examined the effects of cAMP-elevating agents (prostaglandin E2, salmeterol, cilomolast) and steroids (dexamethasone, fluticasone) on basal and stimulated cell migration.
• Evaluated the influence of these agents on cAMP production and cAMP/PKA-dependent gene transcription.

Main Results:

• Platelet-derived growth factor (PDGF), transforming growth factor-alpha, and basic fibroblast growth factor stimulated migration in both ASM and PVSM cells.
• Vascular endothelial growth factor stimulated PVSM cell migration but not ASM cell migration.
• cAMP-mobilizing agents inhibited basal migration and, variably, PDGF-stimulated migration; steroids inhibited basal and PDGF-stimulated migration and enhanced salmeterol's inhibitory effect.

Conclusions:

• cAMP-mobilizing agents and steroids differentially modulate human airway and pulmonary vascular smooth muscle cell migration.
• These agents likely act through distinct mechanisms to control smooth muscle cell movement in the lungs.
• Findings provide insights into potential therapeutic targets for lung diseases involving smooth muscle hyperplasia and migration.